Emicizumab treatment in hemophilia A with inhibitors. A case report and cost-minimization analysis of a non-responder to conventional treatment patient

被引：0

作者：

Martinez Garcia, M. F. ^{[1
]}

Fernandez Caballero, M. ^{[1
]}

Juarez Gimenez, J. C. ^{[2
]}

Serna Pareja, A. ^{[1
]}

Cerda Sabater, M. ^{[1
]}

Johansson, E. ^{[1
]}

Alvarez Martinez, E. ^{[1
]}

Fernandez Sarmiento, C. ^{[1
]}

Bosch Albareda, F. ^{[1
]}

Santamaria Ortiz, A. ^{[1
]}

机构：

[1] Vall dHebron Univ Hosp, Hemophilia Unit, Hematol Dept, Barcelona, Spain

[2] Vall dHebron Univ Hosp, Hemophilia Unit, Dept Hosp Pharm, Barcelona, Spain

来源：

HAEMOPHILIA | 2019年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P191

引用

页码：131 / 131

页数：1

共 50 条

[31] Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient
Emara, Mohamed H.
Radwan, Mohamed I.
VIROLOGY JOURNAL, 2011, 8
[32] Pharmacological treatment of hypertension in patients with type II diabetes a cost-minimization analysis
Berto, P.
Cremonesi, G.
VALUE IN HEALTH, 2006, 9 (06) : A349 - A349
[33] Cost-minimization analysis of treatment of mild-to-moderate hypertension in United States
Stafylas, PC
Sarafidis, PA
Lasaridis, AN
Zouka, MD
VALUE IN HEALTH, 2005, 8 (06) : A107 - A107
[34] Cost-minimization analysis: Radiation treatment with and without a multi-leaf collimator
Foroudi, F
Lapsley, H
Manderson, C
Yeghiaian-Alvandi, R
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (05): : 1443 - 1448
[35] Cost-minimization Analysis of Drugs Used in the Treatment of Asthma and COPD Diseases in India
Payal, Billu
Kumar, Anoop
Saxcna, Harsh
CURRENT DRUG THERAPY, 2021, 16 (01) : 83 - 88
[36] Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient
Mohamed H Emara
Mohamed I Radwan
Virology Journal, 8
[37] Endoscopic treatment options for the management of simple bile leaks: A cost-minimization analysis.
Yacavone, RF
Rumalla, A
Baron, TH
Petersen, BT
GASTROINTESTINAL ENDOSCOPY, 2000, 51 (04) : AB87 - AB87
[38] COST-MINIMIZATION ANALYSIS OF PAN-GENOTYPIC TREATMENT REGIMENS FOR CHRONIC HEPATITIS C
Gordon, S.
Smith, N.
Dieterich, D.
VALUE IN HEALTH, 2019, 22 : S198 - S198
[39] COST-EFFECTIVENESS ANALYSIS OF EMICIZUMAB FOR THE TREATMENT OF PATIENTS WITH HAEMOPHILIA A WITH INHIBITORS IN PORTUGAL
Soares, V
Freitas, L. A.
Cafe, A.
VALUE IN HEALTH, 2019, 22 : S905 - S905
[40] Chronic hepatitis C treatment guidelines need revision: A case of hepatitis C non-responder
Khan, Mahboob A.
Somers, William R.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09) : S386 - S387

← 1 2 3 4 5 →